JOSE DE SOUZA CALDEIRA FILHO

JOSE DE SOUZA CALDEIRA FILHO

Página do item completo

Resultados de Busca

Agora exibindo 1 - 10 de 14

Soft systems methodology as a systemic approach to nuclear safety management
2017 - VIEIRA NETO, ANTONIO S.; GUILHEN, SABINE N.; RUBIN, GERSON A.; CALDEIRA FILHO, JOSE S.; CAMARGO, IARA M.C.
Safety approach currently adopted by nuclear installations is built almost exclusively upon analytical methodologies based, mainly, on the belief that the properties of a system, such as its safety, are given by its constituent parts. This approach, however, doesn’t properly address the complex dynamic interactions between technical, human and organizational factors occurring within and outside the organization. After the accident at Fukushima Daiichi nuclear power plant in March 2011, experts of the International Atomic Energy Agency (IAEA) recommended a systemic approach as a complementary perspective to nuclear safety. The aim of this paper is to present an overview of the systems thinking approach and its potential use for structuring sociotechnical problems involved in the safety of nuclear installations, highlighting the methodologies related to the soft systems thinking, in particular the Soft Systems Methodology (SSM). The implementation of a systemic approach may thus result in a more holistic picture of the system by the complex dynamic interactions between technical, human and organizational factors.
Development of biomolecules labelled with sup(177)Lu for cancer therapy
2006 - ARAUJO, ELAINE B. de; MENGATTI, JAIR; BARBOZA, MARYCEL F. de; COLTURATO, MARIA T.; OSSO JUNIOR, JOAO A.; CALDEIRA FILHO, JOSE de S.; HERRERIAS, ROSANA; MURAMOTO, EMIKO
Hf as competitor in the synthesis of sup(177)Lu-dotatate
2014 - CALDEIRA FILHO, JOSE de S.
Development of somatostatin based radiopharmaceuticals for receptor mediated radionuclide therapy
2007 - ARAUJO, E.B.; CALDEIRA FILHO, J.S.; NAGAMATI, L.T.; MURAMOTO, E.; COLTURATO, M.T.; COUTO, R.; OKASAKI, K.; SUZUKI, M.F.; GUIMARAES, M.I.C.C.
The paper describes the methodology used for and the results of labelling [Tyr3 ]octreotate (TATE) with radioiodine (131I) and [DOTA,Tyr3 ]octreotate (DOTATATE) with 131I and lutetium (177Lu). The quality control and purification procedures are also described. Biodistribution studies were performed in normal Swiss mice and in nude mice bearing AR42J tumours. In vitro studies were used to evaluate the affinity of the radiopharmaceuticals for somatostatin receptors in rat brain cortex and tumour cells. Saturation binding and the internalization of the labelled peptides were determined. The frequency of micronuclei in peripheral blood lymphocytes exposed to different radioactive concentrations of [131I]DOTATATE and [ 177Lu]DOTATATE was evaluated by micronucleus assay.
Induction of micronucleus by [DOTA, Tyr3]octreotate labeled with sup(131)I and sup(177)Lu in peripheral blood lymphocytes IN VITRO
2004 - SUZUKI, M.F.; SILVA, M.A.; CALDEIRA, J.S.; COLTURATO, M.T.; ARAUJO, E.B.; BARTOLINI, P.; OKAZAKI, K.
Genotoxic evaluation of [DOTA,Tyrsup(3)]octreotate labeled with sup(131)I and sup(177)Lu in human peripheral lymphocytes in vitro by micronucleus assay
2005 - SUZUKI, M.F.; SILVA, M.A.; CALDEIRA FILHO, J.S.C.; COLTURATO, M.T.; ARAUJO, E.B.; BARTOLINI, P.; OKAZAKI, K.
The radiolabeled receptor-binding peptides have being used for cancer diagnosis and therapy. The octreotate, a somatostatin analogue peptide, bound to various tumors expressing sst receptors (thyroid, pancreas, prostrate, melanoma and lymphomas). The amount and the type of receptors for somatostatin influence the tissue uptake. The [DOTA, Tyr3 ]octreotate has been used because of its high affinity to somatostatin subtype receptors sstr2 and sstr5. The pharmacokinetic study showed that the blood clearance is rapid and only 9% of the intravenous injected activity remains in human blood after one hour. The aim of this study was to evaluate the cytogenetic effect of radiolabeled [DOTA, Tyr3 ]octreotate in blood cells in vitro, using the cytokinesis-block micronucleus (MN) assay. This technique allows evaluating the mutagenic effects of both endogenous and exogenous agents at chromosome level. Blood samples of healthy donors were collected in heparinized syringes and exposed to different activities of [DOTA, Tyr3 ]octreotate labeled with with 131I (n=3) and 177Lu (n=3), where radioactive concentration ranged from 600 to 5600 kBq/mL, corresponding to an injected activity of 3.1 to 28.9 GBq in a reference man of 70 kg weight. 131I and 177Lu are beta- and gamma-emitters. After one-hour exposition to radiopharmaceuticals at 37o C, the cells were washed with culture medium for removing the non internalised octreotate and cultivated for 72 hours, according to criteria adopted by the IAEA. The results showed a positive correlation between radioactive concentrations (X) and the frequency of binucleated cells with micronuclei (Y) (P<0.05). The model for the best fit of data was the linear one (Y = a + bX). The equation for [131I-DOTA, Tyr3 ]octreotate was Y = (1.634 ± 0.236) + (0.912 ± 0.137) 10-3 X and for [177Lu-DOTA, Tyr3 ]octreotate was Y = (1.715 ± 0.342) + (0.743 ± 0.135) 10-3 X. The non labeled molecule, [DOTA, Tyr3 ]octreotate, has no influence in the induction of cytogenetic damage. The micronucleus assay with rat pancreatic tumor cells (AR42J) that express the sstr2 receptor for somatostatin, submitted to these radiopharmaceuticals, are in course.
Implementacao do sistema da qualidade no Laboratorio de Radiotoxicologia do IPEN
2002 - GABURO, J.C.; CALDEIRA FILHO, J.S.; TODO, A.S.; SANCHES, M.; CAMPOS, L.L.
Comparison of sup(131)I-TYRsup(3)-octreotate and sup(131)I-DOTA-TYRsup(3)Octreotate: the egffect of DOTA on pharmacokinetics and stability
2005 - ARAUJO, E.B. de; MURAMOTO, E.; NAGAMATI, L.T.; CALDEIRA FILHO, J.S.; COUTO, R.M.; SILVA, C.P.G.
sup(177)Lu-DOTATATE: comparative study between sup(177)Lu NRG/ Netherlands anbd sup(177)Lu ORNL/USA
2010 - CALDEIRA FILHO, JOSE de S.
Radiolabeling of substance P with 177 Lu and in vivo evaluation of tumor cell uptake in nude mice: Preliminary results
2008 - PUJATTI, PRISCILLA; BARRIO, OFELIA; CALDEIRA, JOSE; SUZUKI, MIRIAM; ARAUJO, ELAINE